Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, China.
China Pharmaceutical University, College of Basic Medical and Clinical Pharmacy Nanjing, China.
J Psychosom Res. 2022 Jun;157:110787. doi: 10.1016/j.jpsychores.2022.110787. Epub 2022 Mar 22.
Major depressive disorder (MDD) is underscored by daytime dysfunction-associated features, including mood disturbances, impaired cognition, fatigue, and daytime sleepiness. Importantly, the gut-brain axis may represent a potential mechanistic link between MDD and daytime dysfunction. Therefore, this study aimed to explore the gut microbiome composition and daytime dysfunction in Chinese patients with MDD.
We enrolled 36 patients with MDD and 45 healthy controls (HCs) matched by age, sex, and body mass index (BMI). Daytime function including emotion, fatigue, and sleepiness were assessed using the Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Hamilton Anxiety Scale (HAMA), and Hamilton Depression Scale (HAMD). 16S rRNA sequencing was employed to characterize the gut microbiota in stool samples.
The operational taxonomic units (OTUs) OTU255, OUT363 were positively correlated with HAMD and HAMA. OTU244, OTU542 and OTU221 were positively correlated with ESS, HAMD and HAMA. OTU725 and OTU80 were positively correlated with FSS, ESS, HAMD and HAMA, while OTU423 and OTU502 were negatively correlated with all above. Flavonifractor positively correlated with fatigue in patients with MDD and all individuals simultaneously. The correlation between gut microbiome and daytime function was different in MDD and HCs.
We identified several OTUs associated with the severity of fatigue, depression, daytime sleepiness and anxiety in all individuals. Our results revealed the differences in microbiome found between patients with MDD and HCs. These findings provide insights into the potential microbiota changes that occur in MDD, and will enable the development of specific therapeutic strategies for targeting the various symptoms of depression.
重度抑郁症(MDD)的特征是日间功能障碍相关特征,包括情绪障碍、认知障碍、疲劳和日间嗜睡。重要的是,肠道-大脑轴可能是 MDD 与日间功能障碍之间潜在的机制联系。因此,本研究旨在探索中国 MDD 患者的肠道微生物组组成和日间功能障碍。
我们招募了 36 名 MDD 患者和 45 名年龄、性别和体重指数(BMI)匹配的健康对照者(HCs)。使用 Epworth 嗜睡量表(ESS)、疲劳严重程度量表(FSS)、汉密尔顿焦虑量表(HAMA)和汉密尔顿抑郁量表(HAMD)评估日间功能。采用 16S rRNA 测序技术对粪便样本中的肠道微生物群进行特征分析。
操作分类单元(OTUs)OTU255、OTU363 与 HAMD 和 HAMA 呈正相关。OTU244、OTU542 和 OTU221 与 ESS、HAMD 和 HAMA 呈正相关。OTU725 和 OTU80 与 FSS、ESS、HAMD 和 HAMA 呈正相关,而 OTU423 和 OTU502 与上述所有因素呈负相关。Flavonifractor 与 MDD 患者和所有个体的疲劳呈正相关。肠道微生物组与日间功能的相关性在 MDD 患者和 HCs 之间存在差异。
我们确定了一些与所有个体疲劳、抑郁、日间嗜睡和焦虑严重程度相关的 OTUs。我们的研究结果揭示了 MDD 患者和 HCs 之间肠道微生物组的差异。这些发现为 MDD 中发生的潜在微生物组变化提供了深入了解,并将为针对抑郁的各种症状开发特定的治疗策略提供支持。